Lomitapide and high-density lipoprotein function in homozygous familial hypercholesterolaemia

被引：0
|
作者：
Hafiane, Anouar [1 ]
Ronca, Annalisa [1 ]
Incerti, Matteo [1 ]
Rossi, Alessandra [1 ]
Manfredini, Matteo [1 ]
Favari, Elda [1 ]
机构：
[1] McGill Univ, Montreal, PQ, Canada
来源：
JOURNAL OF BIOLOGICAL CHEMISTRY | 2023年 / 299卷 / 03期
基金：
加拿大健康研究院;
关键词：
D O I：
10.1016/j.jbc.2023.103815
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
1809
引用
收藏
页码：S432 / S432
页数：1
相关论文
共 50 条
  • [21] Correction to: Real-World Outcomes with Lomitapide Use in Paediatric Patients with Homozygous Familial Hypercholesterolaemia
    Tawfeg Ben-Omran
    Luis Masana
    Genovefa Kolovou
    Gema Ariceta
    F. Javier Nóvoa
    Allan M. Lund
    Martin P. Bogsrud
    María Araujo
    Osamah Hussein
    Daiana Ibarretxe
    Rosa M. Sanchez-Hernández
    Raul D. Santos
    Advances in Therapy, 2024, 41 : 1765 - 1769
  • [22] Microsomal triglyceride transfer protein inhibitor (lomitapide) efficacy in the treatment of patients with homozygous familial hypercholesterolaemia
    Kolovou, Genovefa
    Diakoumakou, Olga
    Kolovou, Vana
    Fountas, Epameinondas
    Stratakis, Stavros
    Zacharis, Evangelos
    Liberopoulos, Evangelos N.
    Matsouka, Fedra
    Tsoutsinos, Alexandros
    Mastorakou, Irene
    Katsikas, Theodoros
    Mavrogeni, Sophie
    Hatzigeorgiou, Georgios
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2020, 27 (02) : 157 - 165
  • [23] Homozygous familial hypercholesterolaemia
    Macchiaiolo, Marina
    Gagliardi, Maria Giulia
    Toscano, Alessandra
    Guccione, Paolo
    Bartuli, Andrea
    LANCET, 2012, 379 (9823): : 1330 - 1330
  • [24] Efficacy and safety of lomitapide in homozygous familial hypercholesterolaemia: the pan-European retrospective observational study
    D'Erasmo, Laura
    Steward, Kim
    Cefalu, Angelo Baldassare
    Di Costanzo, Alessia
    Boersma, Eric
    Bini, Simone
    Arca, Marcello
    van Lennep, Jeanine Roeters
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 29 (05) : 832 - 841
  • [25] Lomitapide hepatic safety: A long-term retrospective analysis in patients with homozygous familial hypercholesterolaemia
    Cegla, J.
    Larrey, D.
    D'Erasmo, L.
    O'Brien, S.
    Arca, M.
    ATHEROSCLEROSIS PLUS, 2023, 54 : S2 - S3
  • [26] Evaluation of high-density lipoprotein-bound long non-coding RNAs in subjects with familial hypercholesterolaemia
    Scicali, Roberto
    Bosco, Giosiana
    Scamporrino, Alessandra
    Di Mauro, Stefania
    Filippello, Agnese
    Barbagallo, Francesco Di Giacomo
    Spampinato, Salvatore
    Pavanello, Chiara
    Ossoli, Alice
    Di Pino, Antonino
    Calabresi, Laura
    Purrello, Francesco
    Piro, Salvatore
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2024, 54 (01)
  • [27] Impact of High-Density Lipoprotein Function, Rather Than High-Density Lipoprotein Cholesterol Level, on Cardiovascular Disease Among Patients With Familial Hypercholesterolemia
    Tada, Hayato
    Okada, Hirofumi
    Nohara, Atsushi
    Toh, Ryuji
    Harada, Amane
    Murakami, Katsuhiro
    Iino, Takuya
    Nagao, Manabu
    Ishida, Tatsuro
    Hirata, Ken-ichi
    Takamura, Masayuki
    Kawashiri, Masa-aki
    CIRCULATION JOURNAL, 2023, 87 (06) : 806 - +
  • [28] Lomitapide for the Management of Homozygous Familial Hypercholesterolemia
    deGoma, Emil M.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2014, 15 (02) : 109 - 118
  • [29] Long-term efficacy of lipoprotein apheresis in homozygous familial hypercholesterolaemia
    Meier, P
    Blanc, E
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (05) : 738 - 740
  • [30] FAMILIAL AGGREGATION OF HIGH-DENSITY LIPOPROTEIN-CHOLESTEROL
    SOSENKO, JM
    BRESLOW, JL
    MIETTINEN, OS
    ELLISON, RC
    CIRCULATION, 1978, 58 (04) : 30 - 30
12345